National service evaluation for paclitaxel HSRs

Dear BOPA members,

We are all very aware of concerns from our members regarding the ongoing supply shortages of ranitidine. Many hospitals will be forced to amend pre-medication regimens to an alternative where there is sparse experience and it is imperative that we collect data that assures us that patient safety is not compromised.

As Co-chair of BOPA, I would like to invite you to take part in a national service evaluation of paclitaxel pre-medication regimes designed by myself in collaboration with Calum Polwart and Pinkie Chambers. Calum has created a bespoke data collection tool (in Excel format) to minimise the administrative burden.

We strongly encourage you to collaborate on this project, so collectively we can gain a better understanding of the impact of changes in practice results from the shortage.

What to do next?

Email me to let us know you are participating ( I will send you the data collection tool and an instruction sheet for participants, and we can then keep in touch with you throughout the evaluation period.

Although we have logged the evaluation with the BOPA executive committee and A&R subcommittee, you will still need to register your data collection as a service evaluation at your Trust.

Data collection will take place over a six-month period from 1st July to 31st December (the end date may be amended depending on the amount of data received). We will keep a check on numbers collected and complete an interim analysis as soon as possible. Results of the interim analysis as well as the final results will be presented to participating centres in a timely fashion to assist in clinical decision-making.

If you have any concerns or queries, please contact a member of the team via the email addresses given below.

I will look forward to hearing from you!

Best Wishes

Emma Foreman
Co-chair, British Oncology Pharmacy Association


Latest News

By BOPA Committee on 13th April 2021

New Webinar: Vaccine Considerations in Patients Receiving SACT

The Webinar recording of ‘Vaccine Considerations in Patients with Cancer Receiving Systemic Anti-Cancer Therapy (including COVID-19)’ is now available in the e-learning section of the BOPA website for PAID members…

Read article
By BOPA Committee on 12th April 2021

BOPA 2021 Symposium Draft agenda – NOW AVAILABLE

The draft agenda for the forthcoming 24th Annual BOPA Symposium is now available. To view the agenda, please CLICK HERE If you are interested in Chairing a session at the…

Read article
By BOPA Committee on 9th April 2021

COVID-NOW NHS Oncology Workforce study: 2nd Survey NOW OPEN

Are you a UK NHS employee working within an oncology hospital department? Would you like to contribute to some important research exploring the impact of COVID-19 on the oncology workforce?…

Read article
By BOPA on 8th April 2021

Vaccine Considerations in Patients with Cancer Receiving SACT (including COVID-19)

Complimentary Members Only Webinar on April 12, 2021 12:00 PDT, 13:00 MDT, 13:00 CST, 15:00 EDT, 16:00 ADT, 20:00 GMT Registration complimentary for PAID members of CAPhO, ISOPP and BOPA.…

Read article

24th BOPA Symposium 2021

Virtual Symposium 8th to 10th October 2021

Registration is now open!

Early Bird registration for 3 days £49
Late registration for 3 days £175

BOPA non-members:
Early Bird registration for 3 days £240
Late registration for 3 days £375

Please note the early-bird rate applies up until Monday 6th September 2021.

Everything you need to know